12:00 AM
Feb 04, 2013
 |  BC Week In Review  |  Company News  |  Deals

Merck KGaA, Feinstein Institute deal

Merck's Merck Serono S.A. subsidiary partnered with the institute to develop antibodies to treat systemic lupus erythematosus (SLE). Merck Serono will fund a research program at the institute on antibodies that...

Read the full 145 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >